跳至主要内容
临床试验/CTRI/2009/091/000639
CTRI/2009/091/000639已完成3 期

An open label, comparative, multicentric study to assess the efficacy and safety of Zileuton extended-release tablets in comparison with Montelukast sodium tablets in patients suffering from bronchial asthma

Cadila Healthcare Ltd0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients between 18-65 years of age
  • 2.Patients with an established diagnosis of mild to moderate chronic persistent bronchial asthma
  • 3.Informed consent of the patient/relative

排除标准

  • 1.Pregnancy and/or lactation
  • 2.Patients with severe or unstable bronchial asthma or having acute asthmatic attack at the time of enrolment
  • 3.Patients with a clinically relevant respiratory tract infection in the four weeks prior to enrolment
  • 4.Patients with liver dysfunction i.e., active liver disease or persistent hepatic function enzyme elevations ≥3 times the upper limit of normal
  • 5.Patients with any other clinically significant illness
  • 6.Patients with a history of hypersensitivity to any of the components of the study medications
  • 7.Patients with any other serious concurrent illness or malignancy
  • 8.Patients with continuing history of alcohol and / or drug abuse
  • 9.Participation in another clinical trial in the past 3 months

研究者

相似试验